ImmunoGen Inc (IMGN)

[skitahoe]

It should be noted that SNY is taking the naked MAB it licensed from IMGN into a Phase III Trial, and IMGN should receive a $3 million milestone payment.

As I understand it, royalties are just low single digit's, in part because IMGN and other of it's partners are also testing products that also target multi myeloma. It's further acknowledgement of IMGN's skills in product development, but it's probably not a huge moneymaker unless the drug proves to be a blockbuster, then even a small percentage becomes meaningful.

Gary